Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 15

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue

Wallentine, Brad D., Wang, Ying, Tretyachenko-Ladokhina, Vira, Tan, Martha, Senear, Donald F., Luecke, Hartmut·2013·Acta Crystallographica Section D Biological Crystallography

Abstract

To gain insights into the mechanisms by which certain second-site suppressor mutations rescue the function of a significant number of cancer mutations of the tumor suppressor protein p53, X-ray crystallographic structures of four p53 core-domain variants were determined. These include an oncogenic mutant, V157F, two single-site suppressor mutants, N235K and N239Y, and the rescued cancer mutant V157F/N235K/N239Y. The V157F mutation substitutes a smaller hydrophobic valine with a larger hydrophobic phenylalanine within strand S4 of the hydrophobic core. The structure of this cancer mutant shows no gross structural changes in the overall fold of the p53 core domain, only minor rearrangements of side chains within the hydrophobic core of the protein. Based on biochemical analysis, these small local perturbations induce instability in the protein, increasing the free energy by 3.6 kcal mol−1(15.1 kJ mol−1). Further biochemical evidence shows that each suppressor mutation, N235K or N239Y, acts individually to restore thermodynamic stability to V157F and that both together are more effective than either alone. All rescued mutants were found to have wild-type DNA-binding activity when assessed at a permissive temperature, thus pointing to thermodynamic stability as the critical underlying variable. Interestingly, thermodynamic analysis shows that while N239Y demonstrates stabilization of the wild-type p53 core domain, N235K does not. These observations suggest distinct structural mechanisms of rescue. A new salt bridge between Lys235 and Glu198, found in both the N235K and rescued cancer mutant structures, suggests a rescue mechanism that relies on stabilizing the β-sandwich scaffold. On the other hand, the substitution N239Y creates an advantageous hydrophobic contact between the aromatic ring of this tyrosine and the adjacent Leu137. Surprisingly, the rescued cancer mutant shows much larger structural deviations than the cancer mutant alone when compared with wild-type p53. These suppressor mutations appear to rescue p53 function by creating novel intradomain interactions that stabilize the core domain, allowing compensation for the destabilizing V157F mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1107/s0907444913020830

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 43

  1. Adams, 2010, Acta Cryst. D, 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  2. Afonine, 2012, Acta Cryst. D, 68, 352, 10.1107/S0907444912001308 · DOI · Paper page
  3. Aramayo, 2011, Nucleic Acids Res., 39, 8960, 10.1093/nar/gkr386 · DOI · Paper page
  4. Baroni, 2004, Proc. Natl Acad. Sci. USA, 101, 4930, 10.1073/pnas.0401162101 · DOI
  5. Brachmann, 2004, Cell Cycle, 3, 1030, 10.4161/cc.3.8.1076 · doi:10.4161/cc.3.8.1076
  6. Brachmann, 1998, EMBO J., 17, 1847, 10.1093/emboj/17.7.1847 · DOI · Paper page
  7. Brünger, 1998, Acta Cryst. D, 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
  8. Bullock, 2001, Nature Rev. Cancer, 1, 68, 10.1038/35094077 · DOI · Paper page
  9. Bullock, 1997, Proc. Natl Acad. Sci. USA, 94, 14338, 10.1073/pnas.94.26.14338 · DOI · Paper page
  10. Bullock, 2000, Oncogene, 19, 1245, 10.1038/sj.onc.1203434 · DOI · Paper page
  11. Chen, 2010, Acta Cryst. D, 66, 12, 10.1107/S0907444909042073 · DOI · Paper page
  12. Danziger, 2007, Bioinformatics, 23, i104, 10.1093/bioinformatics/btm166 · DOI
  13. Emsley, 2004, Acta Cryst. D, 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  14. Evans, 2006, Acta Cryst. D, 62, 72, 10.1107/S0907444905036693 · DOI · Paper page
  15. Foster, 1999, Science, 286, 2507, 10.1126/science.286.5449.2507 · DOI · Paper page
  16. Joerger, 2004, J. Biol. Chem., 279, 1291, 10.1074/jbc.M309732200 · DOI · Paper page
  17. Joerger, 2006, Proc. Natl Acad. Sci. USA, 103, 15056, 10.1073/pnas.0607286103 · DOI · Paper page
  18. Joerger, 2005, J. Biol. Chem., 280, 16030, 10.1074/jbc.M500179200 · DOI · Paper page
  19. Joerger, 2008, Annu. Rev. Biochem., 77, 557, 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
  20. Jones, 1991, Acta Cryst. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
  21. Krissinel, 2004, Acta Cryst. D, 60, 2256, 10.1107/S0907444904026460 · DOI · Paper page
  22. Kruse, 2009, Cell, 137, 609, 10.1016/j.cell.2009.04.050 · DOI · Paper page
  23. Laskowski, 1996, J. Biomol. NMR, 8, 477, 10.1007/BF00228148 · DOI · Paper page
  24. Melero, 2011, Proc. Natl Acad. Sci. USA, 108, 557, 10.1073/pnas.1015520107 · DOI · Paper page
  25. Nikolova, 1998, Proc. Natl Acad. Sci. USA, 95, 14675, 10.1073/pnas.95.25.14675 · DOI · Paper page
  26. Nikolova, 2000, EMBO J., 19, 370, 10.1093/emboj/19.3.370 · DOI · Paper page
  27. Pace, 1986, Methods Enzymol., 131, 266, 10.1016/0076-6879(86)31045-0 · DOI · Paper page
  28. Pflugrath, 1999, Acta Cryst. D, 55, 1718, 10.1107/S090744499900935X · DOI · Paper page
  29. Riley, 2008, Nature Rev. Mol. Cell Biol., 9, 402, 10.1038/nrm2395 · DOI · Paper page
  30. Rippin, 2002, J. Mol. Biol., 319, 351, 10.1016/S0022-2836(02)00326-1 · DOI · Paper page
  31. Römer, 2006, Angew. Chem. Int. Ed. Engl., 45, 6440, 10.1002/anie.200600611 · DOI · Paper page
  32. Senear, 1991, J. Biol. Chem., 266, 13661, 10.1016/S0021-9258(18)92751-1 · doi:10.1016/s0021-9258(18)92751-1
  33. Storoni, 2004, Acta Cryst. D, 60, 432, 10.1107/S0907444903028956 · DOI · Paper page
  34. Suad, 2009, J. Mol. Biol., 385, 249, 10.1016/j.jmb.2008.10.063 · DOI · Paper page
  35. Tretyachenko-Ladokhina, 2006, J. Mol. Biol., 362, 271, 10.1016/j.jmb.2006.06.085 · DOI
  36. Vogelstein, 2000, Nature (London), 408, 307, 10.1038/35042675 · DOI · Paper page
  37. Vousden, 2002, Nature Rev. Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
  38. Wang, 2003, Cancer Biol. Ther., 2, S55
  39. Wang, 2007, Acta Cryst. D, 63, 276, 10.1107/S0907444906048499 · DOI
  40. Wassman, 2013, Nature Commun., 4, 1407, 10.1038/ncomms2361 · DOI · Paper page
  41. Weinberg, 2004, J. Mol. Biol., 341, 1145, 10.1016/j.jmb.2004.06.071 · DOI · Paper page
  42. Wieczorek, 1996, Nature Med., 2, 1143, 10.1038/nm1096-1143 · DOI
  43. Yu, 2012, Cancer Cell, 21, 614, 10.1016/j.ccr.2012.03.042 · DOI · Paper page

Cited by

See all 15

Metadata

Authors
Wallentine, B. D., Wang, Y., Tretyachenko-Ladokhina, V., Tan, M., Senear, D. F., & Luecke, H.
Venue
Acta Crystallographica Section D Biological Crystallography
Published
2013-09-20
Volume
69
Issue
10
Pages
2146-2156
ISSN
0907-4449
Cited by
15
References
6
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue. https://app.cochat.ai/papers/10.1107/s0907444913020830
The paper
Wallentine, B. D., Wang, Y., Tretyachenko-Ladokhina, V., Tan, M., Senear, D. F., & Luecke, H. (2013). Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue. Acta Crystallographica Section D Biological Crystallography. https://doi.org/10.1107/s0907444913020830

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.